Home NDTV News - Topstories India's Jubilant Signs Licensing Deal For US Pharma Firm's COVID-19 Drug

India's Jubilant Signs Licensing Deal For US Pharma Firm's COVID-19 Drug

A+ A- Print Email

https://ift.tt/eA8V8J
https://www.ndtv.com
India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries,...

from NDTV News - Topstories https://ift.tt/3bqUqQ1
via IFTTT

Labels: NDTV News - Topstories

Post a Comment

Subscribe to: Post Comments (Atom)